文献检索文档翻译深度研究
Suppr Zotero 插件Zotero 插件
邀请有礼套餐&价格历史记录

新学期,新优惠

限时优惠:9月1日-9月22日

30天高级会员仅需29元

1天体验卡首发特惠仅需5.99元

了解详情
不再提醒
插件&应用
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
高级版
套餐订阅购买积分包
AI 工具
文献检索文档翻译深度研究
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2025

Comparative effects of viable Lactobacillus rhamnosus GG and its heat-inactivated paraprobiotic in the prevention of high-fat high-fructose diet-induced non-alcoholic fatty liver disease in rats.

作者信息

Arellano-García Laura Isabel, Milton-Laskibar Iñaki, Martínez J Alfredo, Arán-González Miguel, Portillo María P

机构信息

Nutrition and Obesity Group, Department of Pharmacy and Food Sciences, Faculty of Pharmacy and Lucio Lascaray Research Centre, University of the Basque Country (UPV/EHU), Vitoria-Gasteiz, Spain.

CIBERobn Physiopathology of Obesity and Nutrition, Institute of Health Carlos III, Madrid, Spain.

出版信息

Biofactors. 2025 Jan-Feb;51(1):e2116. doi: 10.1002/biof.2116. Epub 2024 Aug 12.


DOI:10.1002/biof.2116
PMID:39135211
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11680974/
Abstract

Nonalcoholic fatty liver disease (NAFLD) is one of the most prevalent chronic liver alterations worldwide, being gut microbiota dysbiosis one of the contributing factors to its development. The aim of this research is to compare the potential effects of a viable probiotic (Lactobacillus rhamnosus GG) with those exerted by its heat-inactivated paraprobiotic counterpart in a dietary rodent model of NAFLD. The probiotic administration effectively prevented the hepatic lipid accumulation induced by a high-fat high-fructose diet feeding, as demonstrated by chemical (lower TG content) and histological (lower steatosis grade and lobular inflammation) analyses. This effect was mainly mediated by the downregulation of lipid uptake (FATP2 protein expression) and upregulating liver TG release to bloodstream (MTTP activity) in rats receiving the probiotic. By contrast, the effect of the paraprobiotic preventing diet-induced liver lipid accumulation was milder, and mainly derived from the downregulation of hepatic de novo lipogenesis (SREBP-1c protein expression and FAS activity) and TG assembly (DGAT2 and AQP9 protein expression). The obtained results demonstrate that under these experimental conditions, the effects induced by the administration of viable L. rhamnosus GG preventing liver lipid accumulation in rats fed a diet rich in saturated fat and fructose differ from those induced by its heat-inactivated paraprobiotic counterpart.

摘要
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6521/11680974/fa888deb7a95/BIOF-51-0-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6521/11680974/089892c9176f/BIOF-51-0-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6521/11680974/0a7959251f52/BIOF-51-0-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6521/11680974/6907f6ce339c/BIOF-51-0-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6521/11680974/608353ba63e5/BIOF-51-0-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6521/11680974/2581cf79ca58/BIOF-51-0-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6521/11680974/6d7182515b47/BIOF-51-0-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6521/11680974/310a09af68ad/BIOF-51-0-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6521/11680974/35fb38f2724a/BIOF-51-0-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6521/11680974/49de5e6da6d6/BIOF-51-0-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6521/11680974/0b40e1a5eed0/BIOF-51-0-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6521/11680974/54b7cfc7bf31/BIOF-51-0-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6521/11680974/fa888deb7a95/BIOF-51-0-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6521/11680974/089892c9176f/BIOF-51-0-g013.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6521/11680974/0a7959251f52/BIOF-51-0-g011.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6521/11680974/6907f6ce339c/BIOF-51-0-g012.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6521/11680974/608353ba63e5/BIOF-51-0-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6521/11680974/2581cf79ca58/BIOF-51-0-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6521/11680974/6d7182515b47/BIOF-51-0-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6521/11680974/310a09af68ad/BIOF-51-0-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6521/11680974/35fb38f2724a/BIOF-51-0-g009.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6521/11680974/49de5e6da6d6/BIOF-51-0-g010.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6521/11680974/0b40e1a5eed0/BIOF-51-0-g008.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6521/11680974/54b7cfc7bf31/BIOF-51-0-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/6521/11680974/fa888deb7a95/BIOF-51-0-g003.jpg

相似文献

[1]
Comparative effects of viable Lactobacillus rhamnosus GG and its heat-inactivated paraprobiotic in the prevention of high-fat high-fructose diet-induced non-alcoholic fatty liver disease in rats.

Biofactors. 2025

[2]
GG administration partially prevents diet-induced insulin resistance in rats: a comparison with its heat-inactivated parabiotic.

Food Funct. 2023-10-2

[3]
Fibroblast growth factor 21 is required for the therapeutic effects of Lactobacillus rhamnosus GG against fructose-induced fatty liver in mice.

Mol Metab. 2019-9-3

[4]
Lactobacillus rhamnosus GG protects against non-alcoholic fatty liver disease in mice.

PLoS One. 2014-1-27

[5]
Beneficial Effects of Strains on Non-Alcoholic Fatty Liver Disease in High Fat/High Fructose Diet-Fed Rats.

Nutrients. 2020-2-20

[6]
Comparative experimental investigation on the efficacy of mono- and multiprobiotic strains in non-alcoholic fatty liver disease prevention.

BMC Gastroenterol. 2016-3-15

[7]
Protective effects of Lactobacillus rhamnosus GG against dyslipidemia in high-fat diet-induced obese mice.

Biochem Biophys Res Commun. 2016-4-29

[8]
Bifidobacterium adolescentis and Lactobacillus rhamnosus alleviate non-alcoholic fatty liver disease induced by a high-fat, high-cholesterol diet through modulation of different gut microbiota-dependent pathways.

Food Funct. 2020-7-1

[9]
Anti-obesity effect of Lactobacillus rhamnosus LS-8 and Lactobacillus crustorum MN047 on high-fat and high-fructose diet mice base on inflammatory response alleviation and gut microbiota regulation.

Eur J Nutr. 2020-9

[10]
Kangtaizhi Granule Alleviated Nonalcoholic Fatty Liver Disease in High-Fat Diet-Fed Rats and HepG2 Cells via AMPK/mTOR Signaling Pathway.

J Immunol Res. 2020

引用本文的文献

[1]
Advances in the acting mechanism and treatment of gut microbiota in metabolic dysfunction-associated steatotic liver disease.

Gut Microbes. 2025-12

[2]
Changes in Liver Metabolome Induced by Pterostilbene and Resveratrol in a Rat Model of Liver Steatosis.

Mol Nutr Food Res. 2025-8

本文引用的文献

[1]
Hepatocytic Ballooning in Non-alcoholic Steatohepatitis: Bridging the Knowledge Gap and Charting Future Avenues.

Cureus. 2023-9-25

[2]
GG administration partially prevents diet-induced insulin resistance in rats: a comparison with its heat-inactivated parabiotic.

Food Funct. 2023-10-2

[3]
The effect of heat-killed Lactobacillus brevis SBL88 on improving selective hepatic insulin resistance in non-alcoholic fatty liver disease mice without altering the gut microbiota.

J Gastroenterol Hepatol. 2023-10

[4]
-derived postbiotics inhibited digestion of triglycerides, glycerol phospholipids and sterol lipids allosteric regulation of BSSL, PTL and PLA2 to prevent obesity: perspectives on deep learning integrated multi-omics.

Food Funct. 2023-8-14

[5]
prevents hepatic damage in a mouse model of NASH induced by a high-fructose high-fat diet.

Front Microbiol. 2023-3-16

[6]
Beneficial Effects of Viable and Heat-Inactivated GG Administration on Oxidative Stress and Inflammation in Diet-Induced NAFLD in Rats.

Antioxidants (Basel). 2023-3-14

[7]
Heat-Killed Inhibit FL83B Hepatic Lipid Accumulation and High Fat Diet-Induced Fatty Liver Damage in Rats by Activating Lipolysis through the Regulation the AMPK Signaling Pathway.

Int J Mol Sci. 2023-2-24

[8]
Fructose drives de novo lipogenesis affecting metabolic health.

J Endocrinol. 2023-5-1

[9]
ZJUIDS14 alleviates non-alcoholic fatty liver disease in mice in association with modulation in the gut microbiota.

Front Nutr. 2023-1-9

[10]
Diet-induced gut dysbiosis and inflammation: Key drivers of obesity-driven NASH.

iScience. 2022-12-30

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

推荐工具

医学文档翻译智能文献检索